UNC Charlotte’s second annual Invention of the Year Awards Gala celebrated outstanding faculty and student inventors on April ...

Discover the emerging class of degrader-antibody conjugates – a modality that is drawing increasing interest from biotech ...

Vir Biotechnology, Inc. (NASDAQ:VIR) is one of the must-buy small cap stocks to buy. On April 13, Vir Biotechnology, Inc.

With an uptick and increasingly even spread of capital across the space, the BIA’s Martin Turner is optimistic for British biotech’s future.

Seaport will use the funds for its neuropsychiatric drug pipeline, while Hemab will focus on bleeding disorder medicines.

Biomolecular Holdings LLC, a privately-held biotechnology company advancing next-generation antibody architectures, today announced that the United States Patent and Trademark Office (USPTO) granted U ...

Biotech company MindBio Therapeutics (CSE:MBIO) filed a patent application for the world’s first AI model capable of ...

Karnataka has approved a new AI Centre of Excellence in Electronics City, Bengaluru. This decision shows the state’s strong ...

AI-powered drug developer Metis TechBio leads group that includes developers of autonomous driving technology and industrial ...

A new study by researchers at the Icahn School of Medicine at Mount Sinai overturns a longstanding assumption about how mRNA ...

Is VIR a good stock to buy? We came across a bullish thesis on Vir Biotechnology, Inc. on BioEquity Watch’s Substack. In this ...

AV Laboratories is redefining the future of skincare by translating decades of advanced biotechnology research into clinically driven formulations designed for everyday use. Rooted in expertise ...